Uzair B Chaudhary

Summary

Affiliation: Medical University of South Carolina
Country: USA

Publications

  1. pmc Bortezomib in combination with celecoxib in patients with advanced solid tumors: a phase I trial
    John Hayslip
    Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina, USA
    BMC Cancer 7:221. 2007
  2. pmc Phase I dose escalation study of vinorelbine and topotecan combination chemotherapy in patients with recurrent lung cancer
    Matthew A Beldner
    Division of Medical Oncology Hematology, Hollings Cancer Center, Medical University of South Carolina, 96 Jonathan Lucas Street, Charleston, SC 29425, USA
    BMC Cancer 7:231. 2007
  3. ncbi request reprint The evolving role of cytoreductive surgery for metastatic renal cell carcinoma
    Uzair B Chaudhary
    Department of Medicine, Division of Hematology Oncology, Medical University of South Carolina, USA
    Oncology (Williston Park) 17:701-5; discussion 705-6, 711-2. 2003
  4. ncbi request reprint Long-term complications of chemotherapy for germ cell tumours
    Uzair B Chaudhary
    Department of Medicine, Medical University of South Carolina, Charleston, South Carolina 29425, USA
    Drugs 63:1565-77. 2003
  5. ncbi request reprint Acquired amegakaryocytic thrombocytopenia purpura and eosinophilic fasciitis: a long relapsing and remitting course
    Uzair B Chaudhary
    Department of Medicine, Division of Hematology Oncology, Medical University of South Carolina, Charleston, South Carolina 29425, USA
    Am J Hematol 75:146-50. 2004
  6. ncbi request reprint Isolated late recurrence of renal cell carcinoma in the inferior vena cava
    David C Horger
    Department of Urology, Medical University of South Carolina, Charleston, SC, USA
    Can J Urol 11:2467-9. 2004
  7. ncbi request reprint Primary testicular lymphoma and AIDS
    Nitin Verma
    Department of Medicine, Medical University of South Carolina, Charleston, SC, USA
    Ann Clin Lab Sci 40:75-9. 2010
  8. ncbi request reprint Complete response to adriamycin and ifosfamide in a patient with sarcomatoid renal cell carcinoma
    Mohammad H Rashid
    Department of Medicine, Division of Hematology Oncology, Medical University of South Carolina, Charleston, South Carolina, USA
    Am J Clin Oncol 28:107-8. 2005
  9. doi request reprint Testicular lymphoma: an update for clinicians
    Nitin Verma
    Department of Medicine, Division of Hematology Oncology, Medical University of South Carolina, Charleston, South Carolina 29425, USA
    Am J Med Sci 336:336-41. 2008
  10. doi request reprint Toxicity and survival outcomes of hyperfractionated split-course reirradiation and daily concurrent chemotherapy in locoregionally recurrent, previously irradiated head and neck cancers
    John M Watkins
    Department of Radiation Oncology, Medical University of South Carolina, Charleston, South Carolina, USA
    Head Neck 31:493-502. 2009

Collaborators

Detail Information

Publications24

  1. pmc Bortezomib in combination with celecoxib in patients with advanced solid tumors: a phase I trial
    John Hayslip
    Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina, USA
    BMC Cancer 7:221. 2007
    ..The objective of this study was to determine the maximum tolerated dose and dose-limiting toxicities of bortezomib in combination with celecoxib in patients with advanced solid tumors...
  2. pmc Phase I dose escalation study of vinorelbine and topotecan combination chemotherapy in patients with recurrent lung cancer
    Matthew A Beldner
    Division of Medical Oncology Hematology, Hollings Cancer Center, Medical University of South Carolina, 96 Jonathan Lucas Street, Charleston, SC 29425, USA
    BMC Cancer 7:231. 2007
    ....
  3. ncbi request reprint The evolving role of cytoreductive surgery for metastatic renal cell carcinoma
    Uzair B Chaudhary
    Department of Medicine, Division of Hematology Oncology, Medical University of South Carolina, USA
    Oncology (Williston Park) 17:701-5; discussion 705-6, 711-2. 2003
    ..However, this approach is likely to be detrimental in patients with poor performance status. Clinical trials of novel agents remain a priority in this disease...
  4. ncbi request reprint Long-term complications of chemotherapy for germ cell tumours
    Uzair B Chaudhary
    Department of Medicine, Medical University of South Carolina, Charleston, South Carolina 29425, USA
    Drugs 63:1565-77. 2003
    ..Despite these complications, given the potential for cure rates in this young group of patients, the benefits far outweigh the risks...
  5. ncbi request reprint Acquired amegakaryocytic thrombocytopenia purpura and eosinophilic fasciitis: a long relapsing and remitting course
    Uzair B Chaudhary
    Department of Medicine, Division of Hematology Oncology, Medical University of South Carolina, Charleston, South Carolina 29425, USA
    Am J Hematol 75:146-50. 2004
    ..Later in the treatment course, dosing of anti-thymocyte globulin (ATG) appeared to have important beneficial contributions in the management of this patient's disease...
  6. ncbi request reprint Isolated late recurrence of renal cell carcinoma in the inferior vena cava
    David C Horger
    Department of Urology, Medical University of South Carolina, Charleston, SC, USA
    Can J Urol 11:2467-9. 2004
    ..The asymptomatic presentation of this patient with recurrent disease emphasizes the importance of close, long-term surveillance...
  7. ncbi request reprint Primary testicular lymphoma and AIDS
    Nitin Verma
    Department of Medicine, Medical University of South Carolina, Charleston, SC, USA
    Ann Clin Lab Sci 40:75-9. 2010
    ..We report a testicular lymphoma consistent with diffuse large B-cell lymphoma (DLBCL) in an AIDS patient and we review the literature on primary testicular lymphoma in AIDS patients...
  8. ncbi request reprint Complete response to adriamycin and ifosfamide in a patient with sarcomatoid renal cell carcinoma
    Mohammad H Rashid
    Department of Medicine, Division of Hematology Oncology, Medical University of South Carolina, Charleston, South Carolina, USA
    Am J Clin Oncol 28:107-8. 2005
    ..It underscores the fact that the biology of SRCC needs to be studied in more detail for further subcataloging of the disease into diverse prognostic categories...
  9. doi request reprint Testicular lymphoma: an update for clinicians
    Nitin Verma
    Department of Medicine, Division of Hematology Oncology, Medical University of South Carolina, Charleston, South Carolina 29425, USA
    Am J Med Sci 336:336-41. 2008
    ..This review article will focus on the presentation, pathology, patterns of relapse and challenges in improving the outcome of this disease...
  10. doi request reprint Toxicity and survival outcomes of hyperfractionated split-course reirradiation and daily concurrent chemotherapy in locoregionally recurrent, previously irradiated head and neck cancers
    John M Watkins
    Department of Radiation Oncology, Medical University of South Carolina, Charleston, South Carolina, USA
    Head Neck 31:493-502. 2009
    ..Reirradiation of locoregionally recurrent, previously irradiated head/neck cancer may be considered in situations of unresectability, medical inoperability, or adverse pathologic features found at salvage resection...
  11. ncbi request reprint Localized palmar-plantar epidermal hyperplasia: a previously undefined dermatologic toxicity to sorafenib
    Matthew Beldner
    Department of Hematology Oncology, Medical University of South Carolina, Charleston, South Carolina 29425, USA
    Oncologist 12:1178-82. 2007
    ..This particular case represents a unique form of dermatologic toxicity to sorafenib that has not previously been described in the literature...
  12. ncbi request reprint Locally advanced leiomyosarcoma of the urinary bladder: near-complete pathologic response to neoadjuvant gemcitabine and docetaxel
    Rishi Sawhney
    Medical University of South Carolina, Charleston, South Carolina, USA
    Anticancer Drugs 18:745-7. 2007
    ..Further study of this anthracycline-sparing regimen is warranted...
  13. ncbi request reprint Long-term experience with management of renal cell carcinoma involving the inferior vena cava
    Nabil K Bissada
    Medical University of South Carolina, Charleston, South Carolina 29425, USA
    Urology 61:89-92. 2003
    ..To evaluate the long-term outcome and prognosis and influence of patient and tumor characteristics and therapeutic interventions on patients with renal cell carcinoma (RCC) extending to the inferior vena cava (IVC)...
  14. ncbi request reprint Primary mediastinal large B-cell lymphoma in an HIV-infected patient
    David L Milling
    Division of Hematology Oncology, Department of Medicine, Medical University of South Carolina, Charleston, South Carolina 29425, USA
    Am J Med Sci 329:136-8. 2005
    ..Our patient received CHOP (cyclophosphamide, hydroxydaunomycin, Oncovin, prednisone) chemotherapy with granulocyte colony-stimulating factor support but unfortunately died a few days later...
  15. ncbi request reprint Secondary hormonal manipulations in the management of advanced prostate cancer
    Uzair B Chaudhary
    Department of Medicine, Division of Hematology Oncology, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72202, USA
    Can J Urol 12:2666-76. 2005
    ..This article reviews the clinical activity of these agents in management of patients with advanced prostate cancer...
  16. ncbi request reprint A rare case of clear cell adenocarcinoma of the bladder with unique pathological features
    Betsy Adams
    Department of Medicine, Division of Hematology Oncology, Medical University of South Carolina, Charleston, South Carolina 29425, USA
    Am J Med Sci 333:63-5. 2007
    ..We present an important case of clear cell adenocarcinoma of the bladder with a unique staining pattern. We review the literature and discuss the differential diagnosis and various theories concerning the origin of this rare tumor...
  17. ncbi request reprint Cold agglutinin induced autoimmune hemolytic anemia and NK-cell leukemia: a new association
    Amy Skorupa
    Department of Medicine, Division of Hematology Oncology, Medical University of South Carolina, Charleston, SC 29425, USA
    Am J Hematol 82:668-71. 2007
    ..Our patient had a rapid fatal course. To our knowledge this is the first reported case of such an association...
  18. ncbi request reprint Use of low molecular weight heparin and aminocaproic acid in chronic DIC associated with prostate cancer--a case report
    Keisuke Shirai
    Department of Medicine, Division of Hematology Oncology, Medical University of South Carolina, Charleston, SC, USA
    ScientificWorldJournal 7:753-5. 2007
    ..The use of low molecular weight heparin may make management of chronic DIC in prostate cancer more feasible in an out patient setting...
  19. ncbi request reprint Transitional cell carcinoma of the bladder producing parathyroid hormone-related protein (PTHrP)
    Uzair B Chaudhary
    Department of Medicine, Division of Hematology Oncology, Medical University of South Carolina, Charleston, SC, USA
    Can J Urol 11:2136-8. 2004
    ..Literature suggests that these patients present with advanced stage and carry a poor prognosis. The histopathologic features, treatment and prognosis associated with this rare paraneoplastic syndrome are reviewed...
  20. ncbi request reprint Intermittent androgen deprivation therapy for prostate cancer
    Mohammad H Rashid
    Department of Medicine, Medical University of South Carolina, Charleston, South Carolina 29425, USA
    Oncologist 9:295-301. 2004
    ..In this review we discuss the challenges and opportunities of this mode of therapy and shed light on some of the underlying molecular mechanisms...
  21. ncbi request reprint PC-SPES withdrawal response
    Uzair B Chaudhary
    Acta Oncol 43:772-3. 2004
  22. ncbi request reprint High-dose etoposide, thiotepa, and dose-adjusted carboplatin (TVCa) with autologous hematopoietic stem cell rescue as treatment of relapsed or refractory germ cell cancer
    Uzair B Chaudhary
    UCSF Comprehensive Cancer Center, University of California, San Francisco, California, USA
    Am J Clin Oncol 28:130-7. 2005
    ..A significant correlation was seen between intended carboplatin dose and actual AUC. TVCa high-dose chemotherapy is active and well tolerated in patients with relapsed or refractory germ cell cancer...
  23. ncbi request reprint Detection of circulating tumor cells in the peripheral blood of patients with androgen-independent, advanced or metastatic prostate cancer
    Michael C Mitas
    Am J Hematol 83:87. 2008
  24. ncbi request reprint Sacral epithelioid angiosarcoma associated with a bleeding diathesis and spinal epidural hematoma: case report
    Rene O Sanchez-Mejia
    Department of Neurological Surgery, University of California, San Francisco 94143, USA
    J Neurosurg Spine 4:246-50. 2006
    ..This case represents the first report of a primary epithelioid angiosarcoma in the sacrum and emphasizes that the coagulopathy seen in angiosarcoma is also a feature of this epithelioid variant...